US 7550595
Biphenyl compounds useful as muscarinic receptor antagonists
granted A61KA61K31/4545A61K45/06
Quick answer
US patent 7550595 (Biphenyl compounds useful as muscarinic receptor antagonists) held by Theravance, Inc. expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/4545, A61K45/06, A61K9/124, A61K9/1623